Clinical Trials

Company-Supported Clinical Trials

Key clinical trials sponsored by Mallinckrodt for branded drugs are listed on www.clinicaltrials.gov and detailed below, with a link provided to learn more and an indicator of the current phase of development.

Study Title PHASE
1
PHASE
2
PHASE
3
PHASE
4
A MULTICENTER, 2-PART STUDY TO ASSESS THE EFFICACY AND SAFETY OF H.P. ACTHAR® GEL IN SUBJECTS WITH RHEUMATOID ARTHRITIS
More Information >
      X
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin(CONFIRM)
More Information >
    X  
A Safety and Efficacy Study of Uvadex and Extracorporeal Photopheresis (ECP) in Chronic Graft Versus Host Disease
More Information >
X      
A STUDY TO ASSESS THE EFFICACY AND SAFETY OF H.P. ACTHAR GEL IN SUBJECTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
More Information >
      X
A STUDY TO EVALUATE THE DRUG-DRUG INTERACTIONS BETWEEN MORPHINE AND ORALLY OR IV ADMINISTERED ACETAMINOPHEN
More Information >
      X
A study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
More Information >
  X    
Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients (CHART)
More Information >
      X
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
More Information >
  X    
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
More Information >
      X
OBSERVATIONAL REGISTRY OF H.P. ACTHAR® GEL FOR MULTIPLE SCLEROSIS RELAPSE
More Information >
      X
PILOT STUDY TO ASSESS THE EFFICACY & SAFETY OF H.P. ACTHAR GEL IN SUBJECTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS (OPTIONS)
More Information >
      X
REGISTRY EVALUATING PREMATURE AND TERM-NEAR-TERM NEONATES WITH PULMONARY HYPERTENSION RECEIVING INHALED NITRIC OXIDE (PaTTerN)
More Information >
      X
SAFETY AND EFFICACY STUDY OF RAPLIXA™ (FIBRIN SEALANT [HUMAN]) TO TREAT SURGICAL BLEEDING IN CHILDREN
More Information >
  X    
Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS (PODOCYTE)
More Information >
      X
UVADEX® and ECP for the Treatment of Pediatric Patients With Steroid Refractory Acute Graft Versus Host Disease
More Information >
    X